The Asco Post

Today in Oncology

Current News from the World of Oncology Last Updated: Saturday, November 28, 2015 4:02:02 AM

Prognostic Factors Identified in Patients With ALK‑Rearrang...11/18/2015 12:20:12 PM - Matthew Stenger

Yoga Helps Maintain Quality of Life, May Lessen Side Effects in Men Underg...11/18/2015 10:24:05 AM - The ASCO Post

Remembering Mark R. Green, MD, a Leader in Lung Cancer Research and Treatm...May 25, 2015, Volume 6, Issue 9 - Ronald Piana

Kidney Failure and Its Treatment May Impact Cancer Risk11/18/2015 10:11:56 AM - The ASCO Post

10-Year Results of MOSAIC Trial Show Continued Survival Benefit of Adjuvan...11/17/2015 4:07:44 PM - Matthew Stenger

2015 Oncology MeetingsJune 25, 2015, Volume 6, Issue 11 - The ASCO Post

Increased Risk of Second Nonmelanoma Skin Cancer Among Patients Receiving ...11/17/2015 10:30:35 AM - Charlotte Bath

Healthy Diet May Reduce Risk of Ovarian Cancer in African American Women11/17/2015 10:17:36 AM - The ASCO Post

Breast Imaging Reporting and Data System BI-RADSJuly 10, 2015, Volume 6, Issue 12 - Margot J. Fromer

Disparities in Colorectal Cancer Death Rates Take a Large Economic Toll11/17/2015 10:10:49 AM - The ASCO Post

Featured Columnists

Does Low-Dose Radiation Cause Leukemia? Robert Peter Gale MD, PhD, DSc(hc), FACP, FRSM, and F. Owen Hoffman, PhD  

Is Health Care in the United States a Basic Human Right or an Entitlement? Gregory H. Jones, BS, and Hagop Kantarjian, MD  

Discussing Financial Toxicity With Patients Who Have Cancer Jonas A. de Souza, MD  

More Featured Columnists

Expert Opinions

How QOPI® Is Improving Oncology Care  

ASCO Launches TAPUR to Assess the Off-Label Use of Targeted Therapies for Patients With Advanced Cancers  

Engaging Clinicians in the Collection of Cancer Registry Data to Improve Clinical Research  

More Expert Opinions

Meeting News

Chronic Myelogenous Leukemia: What Drug for Which Patient? Neratinib Improves Disease-Free Survival in Early-Stage HER2-Positive Bre... APF530 Superior to Ondansetron in Preventing Chemotherapy-Induced Nausea o... Genomics Now Driving Treatment of Waldenström’s Macroglobulinemia More Meeting News

Journal Spotlight

Accelerated Partial-Breast vs Whole-Breast Irradiation After Surgery for E... ACS Guideline Update on Breast Cancer Screening for Women at Average Risk ASCO Clinical Practice Guideline Update: Systemic Therapy for Stage IV NSC... Checkmate 057: Nivolumab Improves Survival vs Docetaxel in Advanced Nonsq... More Journal Spotlights

Health-Care Policy

Debate Over Physician-Assisted Suicide Continues, State by State ASCO Calls for Comprehensive Payment Reform to Address Issue of Site Neutrality Inconsistent Federal Regulations Undercut U.S. Research Productivity, National Academies’ Report Finds ASCO Asks CMS to Revisit Its Payment Policy to Support Optimal Cancer Care More Health-care Policy

Drugs & Regimens

5-Year Results of GEC-ESTRO Trial of Accelerated Partial-Breast Irradiation vs Whole-Breast Irradiation: Is There Any Impact? Changing the Outlook for Chronic Lymphocytic Leukemia Hypofractionated Radiotherapy Makes Inroads as Primary Treatment of Prostate Cancer Diet and Cancer: How Will We Make Progress? More Drugs & Regimens

Oncology Worldwide

Cancer on the Global Stage: Incidence and Cancer‑Related Mortality in Algeria Geriatric Oncology in Europe: A Commitment to Improving Cancer Care for Older Patients Cancer: Increasing Awareness and Addressing This Lethal Disease on the Global Stage Cancer Incidence and Mortality Rates Worldwide More Oncology Worldwide

Patient's Corner

CAR T-Cell Immunotherapy Saved My Life Shadowed by Cancer My Positive Attitude Is Keeping Me Alive I’m Living a Full and Happy Life With Stage IV Breast Cancer More Patient's Corner

More on Twitter